Ann: Initial Director's Interest Notice - Kilian Kelly, page-11

That's a bit different to starting a FDA trial.

And they haven't started a trial yet. Let alone finished one.

This is from the last AGM:


Since then, after 'reliably' informing the market and shareholders the trial is expected to start by early 2023, they did a CR to pay for it.

We are now passed the halfway mark of the year. And the trial hasn't started and the latest from the company is that the start is months away.

How are you now talking about finishing that trial?

You don't reckon there is something wrong here? Really?

I wish you guys the best of luck but let's not get ahead of ourselves.

Let's discuss this AFTER the trial starts.